194 related articles for article (PubMed ID: 19125705)
1. The role of alpha-lipoic acid in diabetic polyneuropathy treatment.
Bureković A; Terzić M; Alajbegović S; Vukojević Z; Hadzić N
Bosn J Basic Med Sci; 2008 Nov; 8(4):341-5. PubMed ID: 19125705
[TBL] [Abstract][Full Text] [Related]
2. Alpha lipoic acid and glycaemic control in diabetic neuropathies at type 2 diabetes treatment.
Ibrahimpasic K
Med Arch; 2013; 67(1):7-9. PubMed ID: 23678828
[TBL] [Abstract][Full Text] [Related]
3. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy.
Ziegler D; Hanefeld M; Ruhnau KJ; Hasche H; Lobisch M; Schütte K; Kerum G; Malessa R
Diabetes Care; 1999 Aug; 22(8):1296-301. PubMed ID: 10480774
[TBL] [Abstract][Full Text] [Related]
4. Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): a two year multicenter randomized double-blind placebo-controlled trial (ALADIN II). Alpha Lipoic Acid in Diabetic Neuropathy.
Reljanovic M; Reichel G; Rett K; Lobisch M; Schuette K; Möller W; Tritschler HJ; Mehnert H
Free Radic Res; 1999 Sep; 31(3):171-9. PubMed ID: 10499773
[TBL] [Abstract][Full Text] [Related]
5. [Efficacy of thiolepta in diabetic polyneuropathy: results of the study ETIKA].
Strokov IA; Fokina AS; Golovacheva VA; Kochetov AG
Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(5):36-41. PubMed ID: 23739501
[TBL] [Abstract][Full Text] [Related]
6. Thioctic acid for patients with symptomatic diabetic polyneuropathy: a critical review.
Ziegler D
Treat Endocrinol; 2004; 3(3):173-89. PubMed ID: 16026113
[TBL] [Abstract][Full Text] [Related]
7. Alpha-lipoic acid in the treatment of autonomic diabetic neuropathy (controlled, randomized, open-label study).
Tankova T; Koev D; Dakovska L
Rom J Intern Med; 2004; 42(2):457-64. PubMed ID: 15529636
[TBL] [Abstract][Full Text] [Related]
8. Effects of alpha-lipoic acid on microcirculation in patients with peripheral diabetic neuropathy.
Haak E; Usadel KH; Kusterer K; Amini P; Frommeyer R; Tritschler HJ; Haak T
Exp Clin Endocrinol Diabetes; 2000; 108(3):168-74. PubMed ID: 10926311
[TBL] [Abstract][Full Text] [Related]
9. Alpha-lipoic acid in the treatment of diabetic polyneuropathy in Germany: current evidence from clinical trials.
Ziegler D; Reljanovic M; Mehnert H; Gries FA
Exp Clin Endocrinol Diabetes; 1999; 107(7):421-30. PubMed ID: 10595592
[TBL] [Abstract][Full Text] [Related]
10. [Predictors of alpha-lipoic acid treatment efficacy in diabetic polyneuropathy of the lower limbs].
Bregovskiĭ VB; Posokhina OV; Karpova IA
Ter Arkh; 2005; 77(10):15-9. PubMed ID: 16320678
[TBL] [Abstract][Full Text] [Related]
11. Predictors of improvement and progression of diabetic polyneuropathy following treatment with α-lipoic acid for 4 years in the NATHAN 1 trial.
Ziegler D; Low PA; Freeman R; Tritschler H; Vinik AI
J Diabetes Complications; 2016 Mar; 30(2):350-6. PubMed ID: 26651260
[TBL] [Abstract][Full Text] [Related]
12. The effect of alpha-lipoic acid on the neurovascular reflex arc in patients with diabetic neuropathy assessed by capillary microscopy.
Haak ES; Usadel KH; Kohleisen M; Yilmaz A; Kusterer K; Haak T
Microvasc Res; 1999 Jul; 58(1):28-34. PubMed ID: 10388600
[TBL] [Abstract][Full Text] [Related]
13. Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study).
Ziegler D; Hanefeld M; Ruhnau KJ; Meissner HP; Lobisch M; Schütte K; Gries FA
Diabetologia; 1995 Dec; 38(12):1425-33. PubMed ID: 8786016
[TBL] [Abstract][Full Text] [Related]
14. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis.
Ziegler D; Nowak H; Kempler P; Vargha P; Low PA
Diabet Med; 2004 Feb; 21(2):114-21. PubMed ID: 14984445
[TBL] [Abstract][Full Text] [Related]
15. Clinical experience with thioctacid (thioctic acid) in the treatment of distal symmetric polyneuropathy in Korean diabetic patients.
Hahm JR; Kim BJ; Kim KW
J Diabetes Complications; 2004; 18(2):79-85. PubMed ID: 15120701
[TBL] [Abstract][Full Text] [Related]
16. The function of endogenous protective systems in patients with insulin-dependent diabetes mellitus and polyneuropathy: effect of antioxidant therapy.
Strokov IA; Manukhina EB; Bakhtina LY; Malyshev IY; Zoloev GK; Kazikhanova SI; Ametov AS
Bull Exp Biol Med; 2000 Oct; 130(10):986-90. PubMed ID: 11177301
[TBL] [Abstract][Full Text] [Related]
17. The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial.
Ametov AS; Barinov A; Dyck PJ; Hermann R; Kozlova N; Litchy WJ; Low PA; Nehrdich D; Novosadova M; O'Brien PC; Reljanovic M; Samigullin R; Schuette K; Strokov I; Tritschler HJ; Wessel K; Yakhno N; Ziegler D;
Diabetes Care; 2003 Mar; 26(3):770-6. PubMed ID: 12610036
[TBL] [Abstract][Full Text] [Related]
18. [α-Lipoic acid as the main pharmacological drug for in- and outpatient treatment of diabetic polyneuropathy].
Strokov IA; Phokina AS
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(3):50-55. PubMed ID: 28399096
[TBL] [Abstract][Full Text] [Related]
19. Effect of α-lipoic acid on symptoms and quality of life in patients with painful diabetic neuropathy.
Agathos E; Tentolouris A; Eleftheriadou I; Katsaouni P; Nemtzas I; Petrou A; Papanikolaou C; Tentolouris N
J Int Med Res; 2018 May; 46(5):1779-1790. PubMed ID: 29517942
[TBL] [Abstract][Full Text] [Related]
20. Effect of combination therapy consisting of enalapril, α-lipoic acid, and menhaden oil on diabetic neuropathy in a high fat/low dose streptozotocin treated rat.
Davidson EP; Holmes A; Coppey LJ; Yorek MA
Eur J Pharmacol; 2015 Oct; 765():258-67. PubMed ID: 26291662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]